Published in J Virol on June 01, 1990
Adenovirus virus-associated RNA and translation control. J Virol (1991) 3.77
Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev (2000) 2.63
Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J Virol (2002) 2.31
Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol (1995) 2.16
Translation by ribosome shunting on adenovirus and hsp70 mRNAs facilitated by complementarity to 18S rRNA. Genes Dev (2000) 2.09
Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F. EMBO J (2000) 1.52
Genomic analyses of recombinant adenovirus type 11a in China. J Clin Microbiol (2009) 1.41
Tethering of eIF4G to adenoviral mRNAs by viral 100k protein drives ribosome shunting. Genes Dev (2004) 1.30
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication. J Virol (1999) 1.25
Genomic and bioinformatics analysis of HAdV-4, a human adenovirus causing acute respiratory disease: implications for gene therapy and vaccine vector development. J Virol (2005) 1.24
Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex. J Virol (2009) 1.22
A late adenovirus factor induces eIF-4E dephosphorylation and inhibition of cell protein synthesis. J Virol (1994) 1.21
Effects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism. J Virol (2002) 1.19
Genomic and bioinformatics analysis of human adenovirus type 37: new insights into corneal tropism. BMC Genomics (2008) 1.14
RNA-binding properties of a translational activator, the adenovirus L4 100-kilodalton protein. J Virol (1993) 1.12
Control of mRNA export by adenovirus E4orf6 and E1B55K proteins during productive infection requires E4orf6 ubiquitin ligase activity. J Virol (2008) 1.11
Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background. J Virol (2004) 1.08
Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts. J Virol (2006) 1.08
Role of residues 121 to 124 of vesicular stomatitis virus matrix protein in virus assembly and virus-host interaction. J Virol (2006) 1.07
Structural basis for competitive inhibition of eIF4G-Mnk1 interaction by the adenovirus 100-kilodalton protein. J Virol (2004) 1.03
The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export. J Virol (1998) 1.03
mRNA export correlates with activation of transcription in human subgroup C adenovirus-infected cells. J Virol (1996) 1.02
Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products. J Virol (2004) 1.00
Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression. J Virol (2009) 0.99
Protein arginine methylation during lytic adenovirus infection. Biochem J (2004) 0.93
Critical role for arginine methylation in adenovirus-infected cells. J Virol (2007) 0.90
Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo. Mol Ther (2012) 0.90
A novel domain in adenovirus L4-100K is required for stable binding and efficient inhibition of human granzyme B: possible interaction with a species-specific exosite. Mol Cell Biol (2003) 0.86
Arginine methylation of human adenovirus type 5 L4 100-kilodalton protein is required for efficient virus production. J Virol (2009) 0.86
Control of adenovirus early gene expression during the late phase of infection. J Virol (1998) 0.86
The adenovirus L4-22K protein has distinct functions in the posttranscriptional regulation of gene expression and encapsidation of the viral genome. J Virol (2013) 0.86
Constructing chimeric type 12/type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12. J Virol (1994) 0.83
Role of the RNA recognition motif of the E1B 55 kDa protein in the adenovirus type 5 infectious cycle. Virology (2011) 0.83
The adenovirus E1B 55-kilodalton and E4 open reading frame 6 proteins limit phosphorylation of eIF2alpha during the late phase of infection. J Virol (2009) 0.83
Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation. J Virol (2011) 0.83
In vivo transcription from the adenovirus E2 early promoter by RNA polymerase III. Proc Natl Acad Sci U S A (1994) 0.83
The E1B 19-kilodalton protein is not essential for transformation of rodent cells in vitro by adenovirus type 5. J Virol (1993) 0.79
Faithful chaperones. Cell Mol Life Sci (2011) 0.77
Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells. J Virol (2015) 0.77
Oncolytic Replication of E1b-Deleted Adenoviruses. Viruses (2015) 0.77
Generation of cell lines to complement adenovirus vectors using recombination-mediated cassette exchange. BMC Biotechnol (2010) 0.75
Absence of an essential regulatory influence of the adenovirus E1B 19-kilodalton protein on viral growth and early gene expression in human diploid WI38, HeLa, and A549 cells. J Virol (1994) 0.75
Components of Adenovirus Genome Packaging. Front Microbiol (2016) 0.75
Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem (1984) 66.58
Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol (1977) 41.93
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res (1987) 36.83
Spliced segments at the 5' terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci U S A (1977) 14.34
Processing of adenovirus 2-induced proteins. J Virol (1973) 12.52
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst (1973) 11.26
An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA. Cell (1977) 9.44
A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70K U1 snRNP protein. Cell (1989) 7.42
mRNA polyadenylate-binding protein: gene isolation and sequencing and identification of a ribonucleoprotein consensus sequence. Mol Cell Biol (1986) 7.07
Dissociation of mammalian polyribosomes into subunits by puromycin. Proc Natl Acad Sci U S A (1971) 6.77
Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell (1982) 5.80
PUROMYCIN INHIBITION OF PROTEIN SYNTHESIS: INCORPORATION OF PUROMYCIN INTO PEPTIDE CHAINS. Proc Natl Acad Sci U S A (1964) 5.72
Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell (1986) 4.72
Gene gating: a hypothesis. Proc Natl Acad Sci U S A (1985) 4.45
Regulation of the appearance of cytoplasmic RNAs from region 1 of the adenovirus 2 genome. J Mol Biol (1978) 4.30
Double stranded DNA sequencing as a choice for DNA sequencing. Nucleic Acids Res (1988) 4.21
Variation among human 28S ribosomal RNA genes. Proc Natl Acad Sci U S A (1985) 4.04
The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol (1986) 3.36
Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293). Virology (1979) 3.34
Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus. J Mol Biol (1979) 3.32
Effect of adenovirus on metabolism of specific host mRNAs: transport control and specific translational discrimination. Mol Cell Biol (1983) 3.25
Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride. J Gen Virol (1970) 3.20
DNA replication and the early to late transition in adenovirus infection. Cell (1980) 3.17
Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proc Natl Acad Sci U S A (1984) 3.11
Adenovirus VAI RNA prevents phosphorylation of the eukaryotic initiation factor 2 alpha subunit subsequent to infection. Proc Natl Acad Sci U S A (1985) 3.09
Impact of virus infection on host cell protein synthesis. Annu Rev Biochem (1987) 2.98
Phosphorylation of eukaryotic initiation factor 2 during physiological stresses which affect protein synthesis. J Biol Chem (1987) 2.87
The regulation of initiation of mammalian protein synthesis. Prog Nucleic Acid Res Mol Biol (1981) 2.81
Regulation of a protein synthesis initiation factor by adenovirus virus-associated RNA. Nature (1985) 2.80
Adenovirus VAI RNA facilitates the initiation of translation in virus-infected cells. Cell (1984) 2.76
Physical mapping of temperature-sensitive mutations of adenoviruses. J Mol Biol (1975) 2.69
Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology (1983) 2.69
Translational control by adenovirus: lack of virus-associated RNAI during adenovirus infection results in phosphorylation of initiation factor eIF-2 and inhibition of protein synthesis. Proc Natl Acad Sci U S A (1985) 2.53
Genetic analysis of human adenovirus type 5 in permissive and nonpermissive cells. Cold Spring Harb Symp Quant Biol (1975) 2.39
The spliced structures of adenovirus 2 fiber message and the other late mRNAs. Cell (1978) 2.35
Binding of adenovirus VA RNA to mRNA: a possible role in splicing? Nature (1980) 2.28
Structure and organization of the gene coding for the DNA binding protein of adenovirus type 5. Nucleic Acids Res (1981) 2.12
Isolation of temperature-sensitive mutants of adenovirus type 5. J Gen Virol (1971) 2.12
Control of messenger RNA concentration by differential cytoplasmic half-life. Adenovirus messenger RNAs from transcription units 1A and 1B. J Mol Biol (1981) 1.85
The adenovirus tripartite leader may eliminate the requirement for cap-binding protein complex during translation initiation. J Virol (1988) 1.81
The polypeptides of adenovirus. 3. Synthesis in infected cells. Virology (1969) 1.77
Isolation of messenger ribonucleoproteins from mammalian cells. J Mol Biol (1974) 1.72
Control of adenovirus early gene expression: posttranscriptional control mediated by both viral and cellular gene products. Mol Cell Biol (1981) 1.68
Modification of protein synthesis initiation factors and the shut-off of host protein synthesis in adenovirus-infected cells. Virology (1989) 1.66
Identification of adenovirus genes that require template replication for expression. J Virol (1983) 1.59
Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant. Nucleic Acids Res (1985) 1.57
Post-transcriptional restriction of human adenovirus expression in monkey cells. J Virol (1975) 1.39
Alterations of transcription and translation in HeLa cells exposed to amino acid analogs. Mol Cell Biol (1984) 1.34
Expression of dihydrofolate reductase, and of the adjacent EIb region, in an Ad5-dihydrofolate reductase recombinant virus. Nucleic Acids Res (1984) 1.32
Adenovirus proteins associated with mRNA and hnRNA in infected HeLa cells. J Virol (1987) 1.31
Assembly of adenovirus major capsid protein is mediated by a nonvirion protein. Cell (1982) 1.30
Polypeptide structure and encoding location of the adenovirus serotype 2 late, nonstructural 33K protein. J Virol (1983) 1.28
The 19-kDa glycoprotein coded by region E3 of adenovirus. Purification, characterization, and structural analysis. J Biol Chem (1985) 1.28
Characterization of two temperature-sensitive mutants of type 5 adenovirus with mutations in the 100,000-dalton protein gene. J Virol (1981) 1.26
Regulation of adenovirus mRNA formation. Adv Virus Res (1986) 1.26
The nucleotide sequence of the gene for protein IVa2 and of the 5' leader segment of the major late mRNAs of adenovirus type 5. Gene (1981) 1.24
An adenovirus mutant unable to express VAI RNA displays different growth responses and sensitivity to interferon in various host cell lines. Mol Cell Biol (1986) 1.22
Accumulation of early and intermediate mRNA species during subgroup C adenovirus productive infections. Virology (1984) 1.20
Analysis of Ad5 hexon and 100K ts mutants using conformation-specific monoclonal antibodies. Virology (1983) 1.16
Abundant expression of polyomavirus middle T antigen and dihydrofolate reductase in an adenovirus recombinant. J Virol (1987) 1.15
Purification and preliminary immunological characterization of the type 5 adenovirus, nonstructural 100,000-dalton protein. J Virol (1980) 1.08
Characterization of mRNA-protein complexes from mammalian cells. Nucleic Acids Res (1977) 1.04
Shut-off of actin biosynthesis in adenovirus serotype-2-infected cells. J Mol Biol (1984) 1.00
Specific complex of the late nonstructural 100,000-dalton protein with newly synthesized hexon in adenovirus type 2-infected cells. Virology (1983) 0.89
The proteins associated with mRNA from uninfected and adenovirus type 5-infected KB cells. FEBS Lett (1975) 0.86
Messenger ribonucleoprotein complexes in human KB cells infected with adenovirus type 5 contain tightly bound viral-coded '100K' proteins. Eur J Biochem (1979) 0.85
Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science (1988) 5.97
Mapping of adenovirus 2 RNA sequences in lytically infected cells and transformed cell lines. Cold Spring Harb Symp Quant Biol (1975) 4.87
A small nuclear ribonucleoprotein is required for splicing of adenoviral early RNA sequences. Proc Natl Acad Sci U S A (1981) 3.68
The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol (2001) 3.64
Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science (1993) 3.32
Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus. J Mol Biol (1979) 3.32
Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride. J Gen Virol (1970) 3.20
Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels. Proc Natl Acad Sci U S A (1991) 3.14
The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol Cell (2008) 3.05
Comparison of viral RNA sequences in adenovirus 2-transformed and lytically infected cells. J Mol Biol (1975) 2.95
Rifampicin inhibits the growth of some mammalian viruses. Nature (1969) 2.65
Adenovirus transcription. V. Quantitation of viral RNA sequences in adenovirus 2-infected and transformed cells. J Mol Biol (1976) 2.23
Isolation of temperature-sensitive mutants of adenovirus type 5. J Gen Virol (1971) 2.12
Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med (1999) 2.04
Location of additional early gene sequences in the adenoviral chromosome. Cell (1979) 2.03
Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an alpha-helix. Nat Med (1997) 1.83
Characterization of temperature-sensitive mutants of adenovirus type 5: nucleic acid synthesis. Virology (1973) 1.81
An altered subunit configuration associated with the actively transcribed DNA of integrated adenovirus genes. Cell (1977) 1.71
Identification of the adenovirus early proteins and their genomic map positions. Virology (1980) 1.67
Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative roles of changes in heart rate, sympathetic activity, and ventricular dimensions. J Clin Invest (1965) 1.67
Purification of lipoprotein antigens of Echinococcus granulosus from sheep hydatid fluid. Am J Trop Med Hyg (1971) 1.61
A nuclease-hypersensitive element of the human c-myc promoter interacts with a transcription initiation factor. Mol Cell Biol (1989) 1.58
Carbon dioxide embolism treated with hyperbaric oxygen. Can J Anaesth (1989) 1.56
Legionella contamination of dental-unit waters. Appl Environ Microbiol (1995) 1.54
Transcription of adenoviral genetic information in isolated nuclei. Characterization of viral RNA sequences synthesized in vitro. J Biol Chem (1980) 1.47
The use of risk predictions to identify candidates for intermediate care units. Implications for intensive care utilization and cost. Chest (1995) 1.44
The structure of nucleoprotein cores released from adenovirions. Nucleic Acids Res (1983) 1.43
Characterization of temperature-sensitive mutants of adenovirus type 5--serology. J Gen Virol (1972) 1.39
Molecular determinants of the myristoyl-electrostatic switch of MARCKS. J Biol Chem (1996) 1.38
Studies on cardiac dimensions in intact unanesthetized man. V. Effects of nitroglycerin. Circulation (1965) 1.38
Interactions among the three adenovirus core proteins. J Virol (1985) 1.36
The immunological response of the rat to infection with Taenia taeniaeformis. I. Immunoglobulin classes involved in passive transfer of resistance. Immunology (1974) 1.36
A prospective study of the impact of patient preferences on life-sustaining treatment and hospital cost. Crit Care Med (1996) 1.34
The generation and propagation of variegated chromosome structures. Cold Spring Harb Symp Quant Biol (1978) 1.34
Mathematical model for investigating combined seatback-head restraint performance during rear-end impact. Med Biol Eng (1976) 1.32
DNA-binding properties of an adenovirus 289R E1A protein. EMBO J (1988) 1.31
Characterization of single-stranded viral DNA sequences present during replication of adenovirus types 2 and 5. Cell (1976) 1.30
Adenoviral protein VII packages intracellular viral DNA throughout the early phase of infection. EMBO J (1986) 1.28
Adenovirus transcription. II. RNA sequences complementary to simian virus 40 and adenovirus 2DNA in AD2+ND1- and AD2+ND3-infected cells. J Virol (1975) 1.28
Hydatidosis/cysticercosis: immune mechanisms and immunization against infection. Adv Parasitol (1982) 1.27
Identification of proteins and protein domains that contact DNA within adenovirus nucleoprotein cores by ultraviolet light crosslinking of oligonucleotides 32P-labelled in vivo. J Mol Biol (1986) 1.27
Regulation of adenovirus mRNA formation. Adv Virus Res (1986) 1.26
Adenovirus transcription. IV. Synthesis of viral-specific RNA in human cells infected with temperature-sensitive mutants of adenovirus 5. J Virol (1976) 1.25
Expression of adenoviral genetic information in productively infected cells. Biochim Biophys Acta (1982) 1.24
Adenovirus transcription. III. Mapping of viral RNA sequences in cells productively infected by adenovirus type 5. Virology (1976) 1.23
Nucleolin is required for RNA polymerase I transcription in vivo. Mol Cell Biol (2006) 1.23
Accumulation of early and intermediate mRNA species during subgroup C adenovirus productive infections. Virology (1984) 1.20
Effects of heart rate on the dynamics of force development in the intact human ventricle. Circulation (1966) 1.19
Hemodynamic effects of lidocaine in patients with heart disease. Circulation (1968) 1.19
Effects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism. J Virol (2002) 1.19
Glucose and glutamine metabolism in rat thymocytes. Biochem J (1984) 1.19
Oncogenic transformation of hamster embryo cells in vitro by adenovirus type 5. Nature (1973) 1.17
Characterization of temperature-sensitive mutants of adenovirus type 5: synthesis of polypeptides in infected cells. J Gen Virol (1974) 1.16
Studies on digitalis. XV. Effects of cardiac glycosides on myocardial force-velocity relations in the nonfailing human heart. Circulation (1966) 1.15
Kinetic studies on the regulation of rabbit liver pyruvate kinase. Biochem J (1973) 1.15
Hemodynamic effects of glucagon in patients with heart disease. Circulation (1969) 1.15
The pentose phosphate pathway in rabbit liver. Studies on the metabolic sequence and quantitative role of the pentose phosphate cycle by using a system in situ. Biochem J (1971) 1.15
Dislocation after total hip arthroplasty. Treatment with an above-knee hip spica cast. Clin Orthop Relat Res (1983) 1.14
pasilla, the Drosophila homologue of the human Nova-1 and Nova-2 proteins, is required for normal secretion in the salivary gland. Dev Biol (2001) 1.14
Synthesis and processing of simian virus 40-specific RNA in adenovirus-infected, simian virus 40-transformed human cells. J Mol Biol (1983) 1.13
Synthesis and processing of adenoviral RNA in isolated nuclei. J Virol (1979) 1.13
RNA-binding properties of a translational activator, the adenovirus L4 100-kilodalton protein. J Virol (1993) 1.12
New reaction sequences for the non-oxidative pentose phosphate pathway. Biochem J (1978) 1.12
Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus. Eur J Clin Pharmacol (1996) 1.12
Effects of adenovirus infection on rRNA synthesis and maturation in HeLa cells. Mol Cell Biol (1983) 1.11
The profile of IgG and IgG subclasses of onchocerciasis patients. Clin Exp Immunol (1992) 1.11
A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br J Dermatol (1993) 1.11
Partition of E1A proteins between soluble and structural fractions of adenovirus-infected and -transformed cells. J Virol (1986) 1.09
The immunological response of the rat to infection with Taenia taeniaeformis. II. Characterization of reaginic antibody and an allergen associated with the larval stage. Immunology (1974) 1.09
Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts. J Virol (2006) 1.08
The dynamic behaviour of the head and cervical spine during 'whiplash'. J Biomech (1971) 1.07
The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription. J Virol (2006) 1.05
Prion protein structure and scrapie replication: theoretical, spectroscopic, and genetic investigations. Cold Spring Harb Symp Quant Biol (1996) 1.05
Complementation and recombination with temperature-sensitive mutants of adenovirus type 5. J Gen Virol (1971) 1.05
The fate of 14C in glucose 6-phosphate synthesized from [1-14C]Ribose 5-phosphate by enzymes of rat liver. Biochem J (1978) 1.04
Temperature-sensitive mutants of adenovirus defective in interferon induction at non-permissive temperature. Nature (1972) 1.04
Characterization of the adenovirus 2 virion protein, mu. Virology (1989) 1.04
The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export. J Virol (1998) 1.03
Familial myocardial disease with and without obstruction to left ventricular outflow. Clinical, hemodynamic, and angiographic findings. Circulation (1967) 1.03
Influence of temperature on the infectivity of eggs of Echinococcus granulosus in laboratory rodents. J Parasitol (1972) 1.02
Formation of lung colonies by polyoma-transformed rat embryo cells. J Natl Cancer Inst (1966) 1.02
mRNA export correlates with activation of transcription in human subgroup C adenovirus-infected cells. J Virol (1996) 1.02
Interaction between Taenia taeniaeformis and the complement system. J Immunol (1978) 1.02
The transketolase exchange reaction in vitro. Biochem J (1971) 1.02
Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3. FEBS Lett (1999) 1.01
Properties and behavior of hamster embryo cells transformed by human adenovirus type 5. Cold Spring Harb Symp Quant Biol (1975) 1.00
A simplified method for staining mast cells with astra blue. Stain Technol (1981) 0.99
Adenovirus transcription. Curr Top Microbiol Immunol (1976) 0.98
Splicing and the regulation of viral gene expression. Curr Top Microbiol Immunol (1981) 0.98
Onchocerciasis in Sudan: the Abu Hamed focus. Trans R Soc Trop Med Hyg (1985) 0.98
Variations in host responses and the pathogenesis of human onchocerciasis. Rev Infect Dis (1986) 0.98
Quantitative measurement of the L-type pentose phosphate cycle with [2-14C]glucose and [5-14C]glucose in isolated hepatocytes. Biochem J (1980) 0.97
Normal contractile state of hypertrophied myocardium after pulmonary artery constriction in the cat. J Clin Invest (1974) 0.97
Treatment of congestive heart failure with glucagon. Ann Intern Med (1970) 0.97
Antigenic analysis of developmental stages of Ascaris suum. I. Comparison of eggs, larvae and adults. Exp Parasitol (1970) 0.96
Evaluation of purified lipoprotein antigens of Echinococcus granulosus in the immunodiagnosis of human infection. Am J Trop Med Hyg (1971) 0.96
The incidence and management of "medical" complications following cardiac operations. Circulation (1965) 0.95